• Je něco špatně v tomto záznamu ?

Acidification of 24-hour urine in urolithiasis risk testing: An obsolete relic

J. Cadamuro, C. Decho, G. Frans, S. Auer, A. von Meyer, KM. Kniewallner, M. Drerup, E. Heinrich, MH. Keppel, C. Mrazek, TK. Felder, H. Oberkofler, E. Haschke-Becher, U. Kipman, T. Salek, P. Vermeersh, European Federation of Clinical Chemistry and...

. 2022 ; 532 (-) : 1-9. [pub] 20220519

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017866

BACKGROUND: Recommendations on the optimal preservation of 24 h urine for the metabolic work-up in urolithiasis patients are very heterogeneous. In case two such tests with different storage condition recommendations are being analysed, multiple collections would be needed, challenging especially elderly and very young patients. We therefore aimed to evaluate the stability of urine constituents under different storage conditions. MATERIAL AND METHODS: We collected urine samples from ten healthy volunteers and prepared aliquots to be stored either at room temperature or 4 °C. Some aliquots were preserved using hydrochloric acid prior to storage, some thereafter, some using the BD Urine preservation tube and some were not preserved at all. Storage duration was 0, 24, 48 or 72 h. In all samples calcium, magnesium, phosphorus, creatinine, oxalate, citrate and uric acid were measured and compared to the according reference sample. RESULTS: We could not find any significant deviation for any of the analytes and preanalytical treatment conditions compared to the associated reference sample. CONCLUSION: Preservation of 24 h urine for the metabolic evaluation in stone formers might not be necessary for sample storage up to 72 h.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017866
003      
CZ-PrNML
005      
20220804134429.0
007      
ta
008      
220720s2022 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.cca.2022.05.010 $2 doi
035    __
$a (PubMed)35597305
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Cadamuro, Janne $u Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria. Electronic address: j.cadamuro@salk.at
245    10
$a Acidification of 24-hour urine in urolithiasis risk testing: An obsolete relic / $c J. Cadamuro, C. Decho, G. Frans, S. Auer, A. von Meyer, KM. Kniewallner, M. Drerup, E. Heinrich, MH. Keppel, C. Mrazek, TK. Felder, H. Oberkofler, E. Haschke-Becher, U. Kipman, T. Salek, P. Vermeersh, European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group “Preanalytical Phase” (WG-PRE)
520    9_
$a BACKGROUND: Recommendations on the optimal preservation of 24 h urine for the metabolic work-up in urolithiasis patients are very heterogeneous. In case two such tests with different storage condition recommendations are being analysed, multiple collections would be needed, challenging especially elderly and very young patients. We therefore aimed to evaluate the stability of urine constituents under different storage conditions. MATERIAL AND METHODS: We collected urine samples from ten healthy volunteers and prepared aliquots to be stored either at room temperature or 4 °C. Some aliquots were preserved using hydrochloric acid prior to storage, some thereafter, some using the BD Urine preservation tube and some were not preserved at all. Storage duration was 0, 24, 48 or 72 h. In all samples calcium, magnesium, phosphorus, creatinine, oxalate, citrate and uric acid were measured and compared to the according reference sample. RESULTS: We could not find any significant deviation for any of the analytes and preanalytical treatment conditions compared to the associated reference sample. CONCLUSION: Preservation of 24 h urine for the metabolic evaluation in stone formers might not be necessary for sample storage up to 72 h.
650    _2
$a senioři $7 D000368
650    _2
$a vápník $7 D002118
650    _2
$a kyselina citronová $7 D019343
650    _2
$a lidé $7 D006801
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a hořčík $7 D008274
650    _2
$a rizikové faktory $7 D012307
650    12
$a urolitiáza $x diagnóza $x moč $7 D052878
655    _2
$a časopisecké články $7 D016428
700    1_
$a Decho, Cosima $u Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria
700    1_
$a Frans, Glynis $u Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium
700    1_
$a Auer, Simon $u Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria
700    1_
$a von Meyer, Alexander $u Institute for Laboratory Medicine and Medical Microbiology, Medizet, München-Klinik, Munich, Germany
700    1_
$a Kniewallner, Kathrin M $u Institute of Molecular Regenerative Medicine, Paracelsus Medical University, Salzburg, Austria; Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TreCS), Paracelsus Medical University, Salzburg, Austria
700    1_
$a Drerup, Martin $u Department of Urology, Barmherzige Brüder Hospital, Salzburg, Austria
700    1_
$a Heinrich, Elmar $u Department of Urology, Barmherzige Brüder Hospital, Salzburg, Austria
700    1_
$a Keppel, Martin H $u Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria
700    1_
$a Mrazek, Cornelia $u Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria
700    1_
$a Felder, Thomas K $u Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria
700    1_
$a Oberkofler, Hannes $u Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria
700    1_
$a Haschke-Becher, Elisabeth $u Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria
700    1_
$a Kipman, Ulrike $u UT SPSS Statistics, Hallein, Austria
700    1_
$a Salek, Tomas $u Department of Clinical Biochemistry and Pharmacology, The Tomas Bata Hospital in Zlín, Havlíčkovo nábřeží 600, 76275 Zlín, The Czech Republic
700    1_
$a Vermeersh, Pieter $u Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, KU Leuven, Leuven Belgium
710    2_
$a European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group “Preanalytical Phase” (WG-PRE)
773    0_
$w MED00009464 $t Clinica chimica acta; international journal of clinical chemistry $x 1873-3492 $g Roč. 532, č. - (2022), s. 1-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35597305 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134423 $b ABA008
999    __
$a ok $b bmc $g 1821790 $s 1169109
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 532 $c - $d 1-9 $e 20220519 $i 1873-3492 $m Clinica chimica acta $n Clin Chim Acta $x MED00009464
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace